Help ?

IGMIN: あなたがここにいてくれて嬉しいです. お願いクリック '新しいクエリを作成してください' 当ウェブサイトへの初めてのご訪問で、さらに情報が必要な場合は.

すでに私たちのネットワークのメンバーで、すでに提出した質問に関する進展を追跡する必要がある場合は, クリック '私のクエリに連れて行ってください.'

Medicine

Internal Medicine at IgMin Research | Medicine Group

私たちの使命は、学際的な対話を促進し、広範な科学領域にわたる知識の進展を加速することです.

About

Internal medicine, often referred to as general medicine, is a medical specialty that focuses on the prevention, diagnosis, and non-surgical treatment of adult diseases. Internists, or internal medicine physicians, are equipped with a broad understanding of various medical conditions and provide comprehensive care to patients with complex health issues. Their expertise spans across multiple organ systems, allowing them to address diverse health concerns.

The study of internal medicine involves a deep exploration of diseases affecting adults, including chronic conditions, acute illnesses, and preventive healthcare measures. Internal medicine physicians work to identify underlying causes, develop treatment plans, and promote patient wellness. With a holistic approach to patient care, internists play a pivotal role in improving the quality of life for their patients.

  • Cardiovascular Health
  • Gastrointestinal Health
  • Respiratory Health
  • Endocrine Health
  • Renal Health
  • Musculoskeletal Health
  • Neurological Health
  • Immunological Health
  • Geriatric Health
  • Infectious Diseases
  • Metabolic Disorders
  • Hypertension Management
  • Diabetes Care
  • Thyroid Disorders
  • Pulmonary Disorders
  • Liver Diseases
  • Kidney Diseases
  • Arthritis Management
  • Neurological Disorders
  • Autoimmune Conditions
  • Obesity and Weight Management
  • Vaccination and Preventive Health
  • Smoking Cessation
  • Chronic Pain Management
  • Internal Medicine Education

Medicine Group (3)

Mini Review Article ID: igmin234
Cite

Open Access Policy refers to a set of principles and guidelines aimed at providing unrestricted access to scholarly research and literature. It promotes the free availability and unrestricted use of research outputs, enabling researchers, students, and the general public to access, read, download, and distribute scholarly articles without financial or legal barriers. In this response, I will provide you with an overview of the history and latest resolutions related to Open Access Policy.

Mastocytosis: Principles and Pitfalls in the Diagnosis of a Unique Disease
by Martina Rudelius*

Mastocytosis, a hematological neoplasm, manifests with diverse clinical, molecular, and histomorphological features. This review explores the different subtypes of mastocytosis, focusing on the role of molecular pathology and histomorphology in diagnosing systemic mastocytosis (SM). Systemic mastocytosis is characterized by histologically confirmed extracutaneous involvement, presenting a diagnostic challenge due to its rarity and diverse subtypes, ranging from occult SM to mast cell leukemia. The complexity of accurate SM diagnosis underscores... the necessity for a comprehensive understanding of the disease spectrum. Mastocytosis emerges as a rare, multifaceted disease, predominantly affecting children in the cutaneous form and adults in the systemic variant. The review advocates a multidisciplinary diagnostic approach involving experienced hematopathologists and haematooncologists, employing conventional histomorphology, immunohistochemistry, and molecular techniques. This holistic approach is crucial for accurate diagnosis, especially in light of recent therapeutic advances, particularly the growing importance of tyrosine kinase inhibitors (TKI) in the management of mastocytosis.

Haematology PathologyInternal Medicine
Research Article Article ID: igmin201
Cite

Open Access Policy refers to a set of principles and guidelines aimed at providing unrestricted access to scholarly research and literature. It promotes the free availability and unrestricted use of research outputs, enabling researchers, students, and the general public to access, read, download, and distribute scholarly articles without financial or legal barriers. In this response, I will provide you with an overview of the history and latest resolutions related to Open Access Policy.

EB Naevi-like Lesion in Infant Bullous Pemphigoid
by Laura Serpa, Haizza Monteiro, Maria de Oliveira Buffara, Raíssa Rodriguez, Ana Luisa Alves, Viviane Maria Maiolini and Elisa Fontenelle*

Epidermolysis Bullosa Naevi (EBN) is a subset of melanocytic nevi with atypical features arising at sites of blistering in patients with congenital EB. It may be clinically misdiagnosed as melanoma and may represent a challenge for the dermatologist. Bullous Pemphigoid (BP) consists of an autoimmune condition presenting with subepidermal blisters, usually affecting the elderly and rarely observed in children The case is reported of an infant who presented with pruritic erythematous bullous lesions, initially appearing over the trunk and legs wi...th progression to arms and face. Clinical and immunopathological features were consistent with the diagnosis of infant BP. In the course of the disease, he developed a pigmented heterogeneous macule with irregular contour and satellite-dotted lesions, located on the right flank. Dermoscopy revealed a regular pigmented network distributed in an agminated manner interspersed with areas of healthy skin. Due to its similarity to EBN, an expectant approach was carried out. The lesion regressed during the 24-month follow-up. To our knowledge, there is only one literature case report of a child who presented with EBN-like in a previous BP lesion. Our case reinforces the presence of atypical melanocytic nevi in bullous diseases. Knowing this type of lesion clinically and dermatoscopically in patients with bullous dermatoses may prevent unnecessary surgical procedures in children.

Dermatology PaediatricsInternal Medicine
Research Article Article ID: igmin190
Cite

Open Access Policy refers to a set of principles and guidelines aimed at providing unrestricted access to scholarly research and literature. It promotes the free availability and unrestricted use of research outputs, enabling researchers, students, and the general public to access, read, download, and distribute scholarly articles without financial or legal barriers. In this response, I will provide you with an overview of the history and latest resolutions related to Open Access Policy.

Prevalence of Diabetic Retinopathy among Self-reported Newly Diagnosed Diabetics
by Shweta Walia

Introduction: Diabetic Retinopathy (DR) poses a significant threat to individuals with diabetes, leading to visual impairment and blindness if not promptly addressed. This study focuses on the prevalence of diabetic retinopathy among self-reported newly diagnosed diabetics.Material method: This is a prospective study on 200 self-reported newly diagnosed diabetics from April 2022 to May 2023. Patient data, including complaints, diabetes duration, family history, hypertension, and therapy details, were comprehensively analyzed. Complete Ocular ex...aminations including best-corrected visual acuity, intraocular pressure, slit lamp examination, fundus examinations, and Fundus fluorescein angiography were done. Diabetic Retinopathy was graded using a modified ETDRS grading system. Laboratory investigations included complete blood count, fasting and postprandial blood sugar, lipid profile, renal function test, and Hb1AC levels, providing a thorough assessment of patients’ ocular and systemic health.Result: Out of the 200 diabetics, 43.5% had diabetic retinopathy, with a slightly higher prevalence in males (44.64%) compared to females. The age group 50 - 59 had the highest prevalence (74.19%), and Hindus, Muslims, and other communities showed comparable percentages. Family history and hypertension were significant factors, with 88% of those with a family history developing retinopathy. NPDR was predominant (87.35%), while 12.64% had PDR. Clinically Significant Macular Edema (CSME) was present in 59.77%, with 80.76% of these cases having concomitant hypertension. Conclusion: The study emphasizes the imperative for early detection and comprehensive management of diabetic retinopathy among newly diagnosed diabetics. Age, gender, family history, and hypertension emerge as crucial determinants, advocating for integrated care and targeted screening programs to safeguard vision.

Ophthalmology Internal MedicineFamily Medicine